ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

NCT02582125 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Non-small Cell Lung Cancer

Interventions

DRUG: ONO-4538

Sponsor

Ono Pharmaceutical Co., Ltd.